To assess the functional relevance of these findings, we tested whether knockdown of CCL5 and CXCL2 in tumor cells (OE_shCCL5_shCXCL2) could abrogate the anti-tumor effects of NLRP4-OE. This evidence concerns the gene CCL5 and neoplasm.